Category - Pharma Industry News
ABPI and EFPIA call for medicines prioritisation in UK/EU trade talks
Gilead’s oral JAK inhibitor filgotinib wins EU approval
Q&A: Isabel Gibson
Novavax starts first phase 3 COVID-19 vaccine trial in the UK
Lilly’s Verzenio scores a win in early-stage breast cancer
FDA sets January decision date for Xalkori in ALK-positive lymphoma
EMA fast-tracks review of bluebird bio’s LentiGlobin for sickle cell disease
UK COVID-19 vaccine ‘challenge trials’ could intentionally infect participants with virus